Rosetta Genomics Financial Market Data
| Last Close 17-Sep-2008 |
$3.49 |
Price/ Sales Ratio |
-- |
| 52-Week High |
$7.00 |
Price/ Book Ratio |
2.24 |
| 52-Week Low |
$3.26 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
-- |
Price/ Cash Flow Ratio |
-- |
| Market Cap (mil.) |
-- |
Return on Assets |
(74.6%) |
| Shares Outstanding (mil.) |
-- |
Return on Equity |
(84.5%) |
| Dividend Rate |
-- |
Current Ratio |
11.93 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
0.01 |
| # of Institutional Holders |
12 |
% Owned by Institutions |
15.0% |
| Latest Short Interest Ratio |
1.11 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
0.0% |
0.0% |
0.0% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
